| ||||||||||||||
|
|
|||||||||||||

From the *Department of Anesthesiology and Intensive Care, University of Muenster, Muenster, Germany; and
Mayo Clinic and Foundation, Rochester, Minnesota.
Address correspondence and reprint requests to Dirk Breukelmann, MD, University of Muenster, Klinik und Poliklinik fuer Anaesthesiologie und Operative Intensivmedizin, Albert-Schweitzer-Strasse 33, 48149 Muenster, Germany. Address e-mail to breukel{at}uni-muenster.de.
BACKGROUND: Halothane, isoflurane, and sevoflurane exert negative inotropic side effects, generally mediated via a reduced availability of intracellular calcium. Other possible mechanisms include modified intracellular calcium handling, impaired actomyosin cross-bridge cycling, and/or alteration of calcium-induced conformational changes of the regulatory troponin complex.
METHODS: We investigated the effect of halothane, isoflurane, and sevoflurane on calcium-dependent kinetics of isolated human recombinant cardiac troponin C labeled with IAANS (HrcTnCIAANS) using stopped-flow and calcium titration techniques.
RESULTS: Calcium concentration at half-maximal fluorescence intensity (Kd) in the control group was 2.1 ± 0.1 mM. Volatile anesthetics increased calcium sensitivity in a concentration-dependent fashion sevoflurane (Kd 1.51.7 mM, P = 0.001) > halothane (Kd 1.71.9 mM, P < 0.01) > isoflurane (Kd 1.81.9 mM, P < 0.05). The rate constant of conformational changes after rapid dissociation of calcium from HrcTnCIAANS (koff(c)) was moderately prolonged at 4°C by halothane and isoflurane > sevoflurane.
CONCLUSION: These mechanisms may counteract the effects of lower calcium availability, and can be responsible for abbreviated, and possibly incomplete, relaxation of cardiac muscle fibers in the presence of volatile anesthetics.
|